PAMBUKU, ARDI
 Distribuzione geografica
Continente #
NA - Nord America 870
EU - Europa 72
AS - Asia 60
SA - Sud America 1
Totale 1.003
Nazione #
US - Stati Uniti d'America 870
CN - Cina 55
IT - Italia 18
FI - Finlandia 17
SE - Svezia 12
DE - Germania 8
GB - Regno Unito 8
BE - Belgio 3
SG - Singapore 3
NL - Olanda 2
VN - Vietnam 2
EE - Estonia 1
FR - Francia 1
MD - Moldavia 1
PY - Paraguay 1
UA - Ucraina 1
Totale 1.003
Città #
Fairfield 168
Chandler 90
Ann Arbor 79
Ashburn 76
Woodbridge 74
Cambridge 72
Seattle 72
Houston 70
Wilmington 44
Beijing 13
Helsinki 13
San Diego 13
Medford 10
Padova 10
Princeton 10
Des Moines 9
Jinan 7
Nanjing 7
Shenyang 3
Tianjin 3
Fuzhou 2
Guangzhou 2
Hanoi 2
Jiaxing 2
Kilburn 2
Nanchang 2
Roxbury 2
Waanrode 2
Washington 2
Zhengzhou 2
Asunción 1
Atlanta 1
Boardman 1
Borås 1
Brussels 1
Changsha 1
Chisinau 1
Chiswick 1
Ciampino 1
Esslingen am Neckar 1
Hangzhou 1
Hanover 1
Hefei 1
Kharkiv 1
Lanzhou 1
Lappeenranta 1
London 1
Nagold 1
Redwood City 1
San Jose 1
Serina 1
Shanghai 1
Singapore 1
Tallinn 1
Totale 887
Nome #
Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma 163
Effectiveness of antiangiogenic drugs in glioblastoma patients: A systematic review and meta-analysis of randomized clinical trials 145
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor 133
An overview of fotemustine in high-grade gliomas: from single agent to association with bevacizumab. 110
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases 97
Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma 92
Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study 90
Diagnostic Value of Plasma and Urinary 2-Hydroxyglutarate to Identify Patients With Isocitrate Dehydrogenase-Mutated Glioma 85
Suspicious for recurrent low and high grade glioma and indeterminate MRI: the role of 18F-DOPA PET/CT 50
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial 36
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care 16
Totale 1.017
Categoria #
all - tutte 3.621
article - articoli 3.621
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.242


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201950 0 0 0 0 0 0 0 0 0 0 27 23
2019/2020307 21 10 17 96 23 13 25 24 28 33 13 4
2020/2021161 11 12 7 4 9 3 11 31 11 36 24 2
2021/2022182 7 15 14 14 22 9 25 15 8 4 13 36
2022/2023148 24 22 2 28 14 19 0 12 17 2 6 2
2023/202496 2 27 12 11 16 10 7 9 1 1 0 0
Totale 1.017